Allurion Technologies, Inc.

ALUR ·Healthcare, Medical Devices, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2025 FY2024 FY2023 FY2022
Revenue $15.2M $32.1M $53.5M $64.2M
Cost of Revenue $5.7M $10.6M $12.0M $13.5M
Gross Profit $9.6M $21.5M $41.5M $50.7M
Gross Margin 62.8% 67.0% 77.6% 79.0%
Operating Expenses
Research & Development $7.6M $17.4M $27.7M $17.0M
SG&A Expense $21.4M $28.4M $46.0M $15.4M
Operating Income $-30.2M $-50.2M $-79.1M $-32.0M
Operating Margin -198.0% -156.3% -147.9% -49.9%
Interest Expense $10.6M $4.4M
Pretax Income $-28.7M $-6.5M $-82.6M $-37.6M
Income Tax Expense $74.0K $718.0K $264.0K $143.0K
Net Income $-28.8M $-7.2M $-82.8M $-37.7M
Net Margin -188.8% -22.4% -154.9% -58.8%
EPS (Basic) $-3.81 $-1.07 $-19.79 $-12.58
EPS (Diluted) $-3.81 $-1.07 $-19.79 $-12.58
Shares Outstanding (Basic) 7.5M 6.7M 4.3M 3.2M
Shares Outstanding (Diluted) 7.5M 6.7M 4.3M 3.2M
Dividends Per Share